Gilead Sciences (GILD) Intangibles (2009 - 2026)
Gilead Sciences (GILD) recorded Intangibles of $13.42 billion in Q3 2026, down 25.3% from $17.97 billion a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Intangibles of $16.98 billion, down 14.9% from FY2024.
- Annual Intangibles has declined for four straight years, with a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $19.95 billion in FY2024 (-24.6%), $26.45 billion in FY2023 (-8.4%), $28.89 billion in FY2022 (-13.6%) and $33.46 billion in FY2021 (+1.0%).
- The Q3 2026 figure is the lowest quarterly Intangibles since Q3 2020.
- On a year-over-year basis, Intangibles has declined for 19 consecutive quarters, with an average decline of 19.1% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 1.0% in Q4 2021, against a decline of 25.3% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.03 billion (Q2 2026), $16.38 billion (Q1 2026) and $16.98 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 8.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.42 Bn |
| Jun 30, 2026 | 14.03 Bn |
| Mar 31, 2026 | 16.38 Bn |
| Dec 31, 2025 | 16.98 Bn |
| Sep 30, 2025 | 17.97 Bn |
| Jun 30, 2025 | 18.57 Bn |
| Mar 31, 2025 | 19.36 Bn |
| Dec 31, 2024 | 19.95 Bn |
| Sep 30, 2024 | 20.55 Bn |
| Jun 30, 2024 | 22.83 Bn |
| Mar 31, 2024 | 23.43 Bn |
| Dec 31, 2023 | 26.45 Bn |
| Sep 30, 2023 | 27.15 Bn |
| Jun 30, 2023 | 27.75 Bn |
| Mar 31, 2023 | 28.35 Bn |
| Dec 31, 2022 | 28.89 Bn |
| Sep 30, 2022 | 29.44 Bn |
| Jun 30, 2022 | 29.89 Bn |
| Mar 31, 2022 | 30.33 Bn |
| Dec 31, 2021 | 33.46 Bn |
API Access
Gilead Sciences Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();